Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free PLXS Stock Alerts

Plexus (PLXS) Short Interest Ratio & Short Volume

Plexus logo
$266.82 +2.79 (+1.05%)
As of 12:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Plexus Short Interest Overview

As of July 31, 2026, Plexus (PLXS) had a short interest of 738,961 shares sold short, representing 2.81% of the public float. This marks a -12.70% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.1, meaning it would take 2.1 days of the average trading volume of 333,240 shares to cover all short positions.

Current Short Interest
738,961 shares
Previous Short Interest
846,430 shares
Change Vs. Previous Month
-12.70%
Dollar Volume Sold Short
$185.73 million
Short Interest Ratio
2.1 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
26,756,000 shares
Short Percent of Float
2.81%
Today's Trading Volume
74,542 shares
Average Trading Volume
333,240 shares
Today's Volume Vs. Average
22%
Short Selling Plexus?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Plexus and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

PLXS Short Interest Over Time

PLXS Days to Cover Over Time

PLXS Percentage of Float Shorted Over Time

Plexus Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/2026738,961 shares $185.73 million -12.7%2.8%2.14 $251.34
7/15/2026846,430 shares $215.09 million -7.3%3.2%2.95 $254.11
6/30/2026913,438 shares $274.64 million +3.6%3.5%2.3 $300.67
6/15/2026882,096 shares $260.24 million -0.7%3.4%2.83 $295.02
5/29/2026888,365 shares $238.40 million -14.0%3.4%3.69 $268.36
5/15/20261,033,150 shares $267.00 million -8.5%3.9%3.41 $258.43
4/30/20261,128,937 shares $282.89 million -6.5%4.3%2.92 $250.58
4/15/20261,206,921 shares $266.11 million +2.0%4.6%3.76 $220.49
3/31/20261,183,335 shares $239.67 million +2.9%4.5%2.97 $202.54
3/13/20261,149,653 shares $219.28 million +7.3%4.4%3.49 $190.74
2/27/20261,071,854 shares $208.08 million -6.3%4.1%4.2 $194.13
2/13/20261,144,122 shares $230.29 million -2.5%4.4%2.76 $201.28
1/30/20261,173,664 shares $233.95 million +16.3%4.5%2.81 $199.33
1/15/20261,009,222 shares $181.39 million +10.8%3.8%4.26 $179.73
12/31/2025911,294 shares $133.96 million -6.7%3.5%5.16 $147.00
12/15/2025976,649 shares $155.99 million +4.4%3.7%4.87 $159.72
11/28/2025935,823 shares $149.47 million -0.1%3.6%5.28 $159.72
11/14/2025937,114 shares $131.54 million -0.1%3.5%6.1 $140.37
10/31/2025937,601 shares $131.17 million +2.4%3.5%5.23 $139.90
10/15/2025916,100 shares $137.64 million +17.9%3.5%4.9 $150.25
9/30/2025777,100 shares $112.44 million +15.2%2.9%4.1 $144.69
9/15/2025674,700 shares $92.78 million +0.8%2.5%3.6 $137.51
8/31/2025669,300 shares $91.70 million -1.5%2.5%3.9 $137.01
8/15/2025679,700 shares $89.02 million +4.1%2.6%3.9 $130.97
7/31/2025652,700 shares $83.22 million -6.0%2.5%3.8 $127.50
7/15/2025694,500 shares $93.44 million +2.2%2.6%4.3 $134.55
6/30/2025679,600 shares $91.96 million +25.2%2.6%4.2 $135.31
6/15/2025543,000 shares $70.71 million +1.3%2.0%3.4 $130.22
5/31/2025535,800 shares $70.04 million -8.4%2.0%3 $130.72
5/15/2025585,100 shares $77.64 million -0.7%2.2%3.2 $132.70
4/30/2025589,100 shares $72.12 million -3.0%2.2%3.1 $122.43
4/15/2025607,300 shares $74.20 million +11.4%2.3%3 $122.18
3/31/2025545,200 shares $69.86 million -16.8%2.1%2.7 $128.13
3/15/2025655,400 shares $81.41 million +3.0%2.5%3.2 $124.21
2/28/2025636,400 shares $84.59 million +3.4%2.4%3.3 $132.92
2/15/2025615,600 shares $85.69 million -3.6%2.3%3.2 $139.19
1/31/2025638,400 shares $90.47 million +1.6%2.4%3.2 $141.71
1/15/2025628,600 shares $105.03 million +1.4%2.4%3.1 $167.08
12/31/2024619,700 shares $96.97 million +4.9%2.3%3.4 $156.48
12/15/2024590,700 shares $98.12 million +9.9%2.2%3.2 $166.11
BSEM Is Officially on Nasdaq... The Next Chapter Begins! (Ad)

BioStem Technologies (NASDAQ: BSEM) debuted on Nasdaq August 7th, marking its move from OTC markets into a new phase of visibility for the regenerative medicine company. The company's acquisition of BioTissue assets expanded its Neox and Clarix product portfolios and strengthened hospital relationships, following seven consecutive profitable quarters and its proprietary BioREtain technology platform. With expanding clinical validation and a focus on the multi-billion-dollar wound care market, BSEM is drawing attention as it scales hospital adoption.tc pixel

See why BioStem Technologies is becoming a closely watched regenerative medicine stock
11/30/2024537,300 shares $88.33 million +5.0%2.0%3.3 $164.40
11/15/2024511,800 shares $78.37 million +46.9%1.9%3.2 $153.13
10/31/2024348,400 shares $50.20 million -0.9%1.3%2.4 $144.10
10/15/2024351,400 shares $47.76 million -6.7%1.3%2.5 $135.91
9/30/2024376,700 shares $51.50 million -27.2%1.4%2.7 $136.71
9/15/2024517,400 shares $65.30 million +21.9%1.9%3.5 $126.21
8/31/2024424,300 shares $54.36 million +29.6%1.6%3 $128.11
8/15/2024327,500 shares $40.45 million +19.5%1.2%2.4 $123.51
7/31/2024274,000 shares $35.12 million -21.3%1.0%2.1 $128.17
7/15/2024348,200 shares $39.27 million +11.1%1.3%2.7 $112.79
6/30/2024313,400 shares $32.34 million -21.2%1.2%2.6 $103.18
6/15/2024397,700 shares $40.62 million -8.2%1.5%3.6 $102.13
5/31/2024433,400 shares $47.73 million -18.6%1.6%3.9 $110.14
5/15/2024532,400 shares $57.70 million -9.4%2.0%4.6 $108.38
4/30/2024587,700 shares $59.36 million -7.2%2.2%4.8 $101.01
4/15/2024633,400 shares $60.01 million +9.6%2.4%5.2 $94.75
3/31/2024578,200 shares $54.82 million -2.0%2.1%4.8 $94.82
3/15/2024590,100 shares $54.15 million +24.5%2.2%5 $91.76
2/29/2024474,000 shares $44.75 million +19.9%1.8%3.8 $94.40
2/15/2024395,500 shares $38.31 million +34.7%1.5%3.3 $96.87
1/31/2024293,700 shares $27.82 million -9.2%1.1%2.5 $94.72
1/15/2024323,400 shares $33.29 million -22.2%1.2%2.7 $102.93
12/31/2023415,900 shares $44.97 million +3.2%1.5%3.5 $108.13
12/15/2023403,100 shares $44.08 million +2.1%1.5%3.3 $109.35
11/30/2023395,000 shares $40.25 million -21.4%1.5%3.3 $101.89
11/15/2023502,200 shares $53.62 million -7.2%1.9%4.3 $106.77
10/31/2023541,300 shares $53.22 million +2.6%2.0%4.6 $98.32
10/15/2023527,500 shares $49.45 million +16.1%2.0%4.8 $93.74
9/30/2023454,200 shares $42.23 million -0.1%1.7%4.2 $92.98
9/15/2023454,500 shares $40.92 million +2.4%1.7%4.4 $90.04
8/31/2023443,700 shares $45.06 million +6.7%1.7%4.2 $101.55
8/15/2023415,800 shares $40.18 million +18.0%1.6%3.8 $96.63
7/31/2023352,500 shares $34.72 million +4.2%1.3%3.3 $98.49
7/15/2023338,200 shares $33.89 million -31.5%1.3%2.8 $100.21
6/30/2023493,500 shares $48.48 million -24.0%1.8%3.8 $98.24
6/15/2023649,600 shares $62.48 million -2.8%2.4%4.6 $96.18
5/31/2023668,000 shares $60.57 million +9.3%2.5%4.6 $90.68
5/15/2023611,100 shares $52.78 million +11.4%2.3%4.2 $86.37
4/30/2023548,600 shares $47.99 million +1.7%2.0%3.5 $87.47
4/15/2023539,400 shares $52.02 million +9.1%2.0%2.9 $96.44
3/31/2023494,600 shares $48.26 million -18.9%1.8%2.7 $97.57
3/15/2023610,200 shares $57.18 million -11.3%2.3%3.6 $93.70
2/28/2023688,100 shares $65.98 million +5.9%2.5%3.9 $95.89
2/15/2023649,900 shares $64.99 million +3.8%2.4%3.8 $100.00
1/31/2023625,900 shares $60.08 million -33.9%2.3%3.6 $95.99
1/15/2023946,900 shares $107.35 million +1.1%3.5%6.2 $113.37
12/30/2022936,900 shares $96.44 million +5.5%3.5%6.2 $102.93
12/15/2022888,300 shares $93.63 million +1.6%3.3%5.8 $105.40
11/30/2022874,100 shares $96.34 million -9.7%3.2%6.4 $110.22
11/15/2022968,100 shares $102.41 million +5.9%3.6%7.1 $105.78
BSEM Is Officially on Nasdaq... The Next Chapter Begins! (Ad)

BioStem Technologies (NASDAQ: BSEM) debuted on Nasdaq August 7th, marking its move from OTC markets into a new phase of visibility for the regenerative medicine company. The company's acquisition of BioTissue assets expanded its Neox and Clarix product portfolios and strengthened hospital relationships, following seven consecutive profitable quarters and its proprietary BioREtain technology platform. With expanding clinical validation and a focus on the multi-billion-dollar wound care market, BSEM is drawing attention as it scales hospital adoption.tc pixel

See why BioStem Technologies is becoming a closely watched regenerative medicine stock
10/31/2022913,900 shares $89.93 million -16.9%3.4%6.7 $98.40
10/15/20221,100,000 shares $97.24 million +3.8%4.1%8.6 $88.40
9/30/20221,060,000 shares $92.81 million +1.0%3.9%8.9 $87.56
9/15/20221,050,000 shares $95.35 million +2.9%3.9%8.6 $90.81
8/31/20221,020,000 shares $95.60 million -2.9%3.8%8.4 $93.73
8/15/20221,050,000 shares $99.65 million +2.9%3.9%8.6 $94.90
7/31/20221,020,000 shares $95.83 million -1.0%3.8%8.6 $93.95
7/15/20221,030,000 shares $81.79 million +1.0%3.8%8.8 $79.41
6/30/20221,020,000 shares $80.07 million -1.9%3.8%8.6 $78.50
6/15/20221,040,000 shares $86.25 million +1.0%N/A8.9 $82.93
5/31/20221,030,000 shares $87.34 million +4.2%3.8%9.1 $84.80
5/15/2022988,700 shares $81.24 million +18.1%3.7%7.7 $82.17
4/30/2022837,200 shares $67.93 million +0.7%3.1%6 $81.14
4/15/2022831,500 shares $64.60 million -3.8%3.0%5.6 $77.69
3/31/2022864,000 shares $70.68 million -7.9%3.2%5.7 $81.81
3/15/2022938,200 shares $77.13 million +19.4%3.4%6.4 $82.21
2/28/2022786,000 shares $64.04 million +5.8%2.9%5 $81.47
2/15/2022743,200 shares $61.31 million +40.5%2.7%5 $82.50
1/31/2022529,000 shares $41.01 million +40.5%1.9%4.1 $77.52
1/15/2022376,600 shares $34.97 million -18.9%1.4%3.3 $92.86
12/31/2021464,600 shares $44.55 million -8.5%1.7%4.6 $95.89
12/15/2021507,700 shares $47.13 million +1.4%1.9%5 $92.84
11/30/2021500,600 shares $42.12 million -6.0%1.8%5.4 $84.14
11/15/2021532,800 shares $49.24 million -3.4%2.0%5.9 $92.41
10/29/2021551,700 shares $48.17 million -15.8%2.0%6.2 $87.32
10/15/2021655,200 shares $61.24 million +2.6%2.4%7.6 $93.47
9/30/2021638,700 shares $57.11 million -15.3%2.3%7 $89.41
9/15/2021753,600 shares $69.03 million +4.6%2.7%7.7 $91.60
8/31/2021720,300 shares $66.15 million +6.4%2.6%7.4 $91.83

PLXS Short Interest - Frequently Asked Questions

Short interest is the volume of Plexus shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 738,961 shares of PLXS short. 2.81% of Plexus' shares are currently sold short. Learn More on Plexus' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PLXS shares currently have a short interest ratio of 2.1. Learn More on Plexus's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.81% of Plexus' floating shares are currently sold short.

Plexus saw a decline in short interest in July. As of July 31st, there was short interest totaling 738,961 shares, a decline of 12.7% from the previous total of 846,430 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.81% of Plexus' shares are currently sold short. Here is how the short interest of companies in the sector of "technology" compare to Plexus: Advanced Energy Industries, Inc. (4.75%), Avnet, Inc. (9.63%), Flex Ltd. (2.54%), Littelfuse, Inc. (6.10%), Sanmina Corporation (2.91%), Super Micro Computer, Inc. (18.12%), Arista Networks, Inc. (1.04%), Benchmark Electronics, Inc. (4.01%), CTS Corporation (2.94%), Jabil, Inc. (3.35%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling PLXS is an investing strategy that aims to generate trading profit from Plexus as its price is falling. PLXS shares are trading up $2.79 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Plexus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PLXS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PLXS, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like PLXS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:PLXS is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
BSEM Is Officially on Nasdaq... The Next Chapter Begins!
BioStem Technologies (NASDAQ: BSEM) debuted on Nasdaq August 7th, marking its move from OTC markets into a new...
Huge Alerts | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel